High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation-Reference-Cited by-同舟云学术

High-dose acyclovir and pre-emptive ganciclovir in prevention of cytomegalovirus disease in pediatric patients following peripheral blood stem cell transplantation

Published:2004-03-22 Issue:9 Volume:33 Page:931-935
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Hazar V,Kansoy S,Küpesiz A,Aksoylar S,Kantar M,Yeşilipek A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704463.pdf

Reference27 articles.

1. Meyers JD, Flournoy N, Thomas E . Risk factors for cytomegalovirus infection after human bone marrow transplantation. J Infect Dis 1986; 153: 478–488.

2. Forman SJ, Zaia JA . Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood 1994; 83: 2392–2398.

3. Wingard JR, Chen DYH, Burns WH et al. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 1998; 71: 1432–1437.

4. Osarogiagbon RU, Defor TE, Weisdorf MA et al. CMV antigenemia following bone marrow transplantation: risk factors and outcomes. Biol Blood Marrow Transplant 2000; 6: 280–288.

5. Broers AE, van der Hold R, van Esser JWJ et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 2000; 95: 2240–2245.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience;Bone Marrow Transplantation;2023-08-23

2. The Impact of High CMV Viral Load and Refractory CMV Infection on Pediatric HSCT Recipients with Underlying Non-Malignant Disorder;Journal of Clinical Medicine;2022-09-01

3. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation;Transplant Infectious Disease;2018-07-20

4. Cytomegalovirus Treatment in Pediatric Hematopoietic Stem Cell Transplant Patients;Journal of Pediatric Hematology/Oncology;2017-05

5. Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2015-10